Results 171 to 180 of about 19,105 (226)

Structural Basis for BD1-Preferring 2,4-Disubstituted Pyrimidine BRDT Inhibitors. [PDF]

open access: yesJ Med Chem
Liang T   +11 more
europepmc   +1 more source

Esterase-responsive albumin-binding PROTAC-mediated BRD4 degradation for cancer immunotherapy. [PDF]

open access: yesTheranostics
Lee H   +13 more
europepmc   +1 more source

Crosstalk between integrin signaling and NAD⁺ biosynthetic pathways promotes glycolysis, proliferation, survival, and tumor growth in triple-negative breast cancer. [PDF]

open access: yesOncogene
Spellecy O   +22 more
europepmc   +1 more source

Epigenetically controlled endothelial promyelocytic leukemia drives liver inflammation and fibrosis. [PDF]

open access: yesJ Clin Invest
Gan C   +22 more
europepmc   +1 more source

Cartilage targeting hydrogel nanoplatform degrades BRD4 to alleviate osteoarthritis via Nav1.7 axis. [PDF]

open access: yesNat Commun
Zhao Q   +21 more
europepmc   +1 more source

Histone acetylation-dependent clustering of BRD2 instructs transcription dynamics. [PDF]

open access: yesNat Genet
Erdogdu NU   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy